首页 > 最新文献

Journal of Indian System of Medicine最新文献

英文 中文
Prameha (diabetes): A scoping review of updates from Keraliya Ayurveda literature Prameha(糖尿病):从Keraliya阿育吠陀文献更新的范围综述
Pub Date : 2023-01-01 DOI: 10.4103/jism.jism_63_22
A. Mahapatra, Rajagopala Shrikrishna, N. Ojha, Prasanth Dharmarajan, A. Dileep, Karthika Parameswaran
The term “Prameha” denotes a wide variety of diseases, among which diabetes is the most widely used one. There are several regional variations in the pieces of knowledge and practices about Prameha. This article compiles the contributions of Kerala’s Ayurvedic textbooks in the diagnosis and management of Prameha and their relevance in the current scenario for their availability and evidence to substantiate their effectiveness. Textbooks written by physicians of Kerala were screened for eligibility (relevant contributions in Prameha). Eleven texts were found eligible and scrutinized. The diagnostic and therapeutic contributions were categorized, and the therapeutic contributions were searched on PubMed, Scopus, and Google Scholar for supporting evidence. The 128 contributions obtained were as follows: diagnostic: etiological factors (1), clinical features (4), and diagnoses (3); and therapeutic: lines of management (8), pharmacological interventions (50), nonpharmacological interventions (7), procedures (15), and diet and regimen modifications (40). All single drugs and six formulations were available, and supporting evidence was available for 13 drugs mentioned and two proprietary medicines containing these drugs. The contributions have raw material availability and preclinical evidence. Further research and availability of these are to be ensured for these leads to be useful in managing Prameha on larger scale.
“Prameha”一词表示各种各样的疾病,其中糖尿病是使用最广泛的一种。关于Prameha的知识和实践有几个地区的差异。本文汇编了喀拉拉邦阿育吠陀教科书在Prameha的诊断和管理方面的贡献,以及它们在当前情况下的相关性,以证明它们的有效性。由喀拉拉邦的医生编写的教科书被筛选为合格(在Prameha的相关贡献)。11个文本被发现符合条件并进行了仔细审查。对诊断和治疗贡献进行分类,并在PubMed、Scopus和Google Scholar上搜索治疗贡献的支持证据。获得的128条贡献如下:诊断:病因(1)、临床特征(4)和诊断(3);治疗方面:管理方法(8项)、药物干预(50项)、非药物干预(7项)、手术(15项)、饮食和养生法调整(40项)。所有单一药物和6种制剂均可获得,所提到的13种药物和含有这些药物的两种专有药物均可获得支持性证据。贡献有原始材料的可用性和临床前证据。为了使这些线索在更大规模地管理Prameha中有用,需要确保进一步的研究和这些线索的可用性。
{"title":"Prameha (diabetes): A scoping review of updates from Keraliya Ayurveda literature","authors":"A. Mahapatra, Rajagopala Shrikrishna, N. Ojha, Prasanth Dharmarajan, A. Dileep, Karthika Parameswaran","doi":"10.4103/jism.jism_63_22","DOIUrl":"https://doi.org/10.4103/jism.jism_63_22","url":null,"abstract":"The term “Prameha” denotes a wide variety of diseases, among which diabetes is the most widely used one. There are several regional variations in the pieces of knowledge and practices about Prameha. This article compiles the contributions of Kerala’s Ayurvedic textbooks in the diagnosis and management of Prameha and their relevance in the current scenario for their availability and evidence to substantiate their effectiveness. Textbooks written by physicians of Kerala were screened for eligibility (relevant contributions in Prameha). Eleven texts were found eligible and scrutinized. The diagnostic and therapeutic contributions were categorized, and the therapeutic contributions were searched on PubMed, Scopus, and Google Scholar for supporting evidence. The 128 contributions obtained were as follows: diagnostic: etiological factors (1), clinical features (4), and diagnoses (3); and therapeutic: lines of management (8), pharmacological interventions (50), nonpharmacological interventions (7), procedures (15), and diet and regimen modifications (40). All single drugs and six formulations were available, and supporting evidence was available for 13 drugs mentioned and two proprietary medicines containing these drugs. The contributions have raw material availability and preclinical evidence. Further research and availability of these are to be ensured for these leads to be useful in managing Prameha on larger scale.","PeriodicalId":16051,"journal":{"name":"Journal of Indian System of Medicine","volume":"16 1","pages":"51 - 59"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85029079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent advances in diagnosis and management of ischemic heart diseases in perspective of contemporary and Ayurveda medicine—a comprehensive review 当代和阿育吠陀医学视角下缺血性心脏病诊断和治疗的最新进展
Pub Date : 2023-01-01 DOI: 10.4103/jism.jism_92_22
Aishwarya Joglekar, M. Vyas, M. Bhojani
Ischemic heart disease (IHD) or commonly known as coronary heart disease is considered as of the important cause of morbidity and mortality across the globe. This condition affects both the structure and function of heart muscle. Its prevalence should be considered since the advent of human life as even classical texts of Ayurveda have given ample emphasis on physiology and pathology of Hridroga (heart diseases). This is thus a topic of interest for the cardiologists, Ayurveda physicians, and general physicians. In order to cope with the transformations in the field of medicine, especially critical care, one must be well versed with the recent advances especially concerning this critical field of cardiology. The available classical literature regarding Hridroga and contemporary literature pertaining to IHD is reviewed in the present study with the help of robust search of different databases, published scientific works to present solid knowledge foundation for effective diagnosis, management, and research opportunities concerning filed of cardiology. The advances concerning the different clinical and preclinical trials on interventional drugs in treatment of IHD along with the different observational and exploratory studies done to understand the pathophysiology of Hridroga are highlighted in this article. Encouraging findings were achieved by the means of a thorough review put forth in the article which elaborates to highlight the recent advances in the research, diagnosis, management, and prevention of IHD in terms of both Ayurvedic and contemporary approaches.
缺血性心脏病(IHD)或俗称冠心病被认为是全球发病率和死亡率的重要原因之一。这种情况会影响心肌的结构和功能。自人类诞生以来,就应该考虑到它的普遍性,因为即使是阿育吠陀的经典文献也充分强调了Hridroga(心脏病)的生理学和病理学。因此,这是心脏病专家、阿育吠陀医生和普通医生感兴趣的话题。为了应对医学领域的转变,特别是重症监护,一个人必须精通最近的进展,特别是关于心脏病学这一关键领域。在本研究中,通过对不同数据库的强大搜索,对有关Hridroga的现有经典文献和有关IHD的当代文献进行了回顾,并发表了科学著作,为心脏病学领域的有效诊断,管理和研究机会提供坚实的知识基础。本文重点介绍了介入药物治疗IHD的不同临床和临床前试验的进展,以及为了解Hridroga的病理生理所做的不同观察性和探索性研究。通过文章中提出的全面审查,取得了令人鼓舞的发现,该文章详细介绍了阿育吠陀和当代方法在IHD研究,诊断,管理和预防方面的最新进展。
{"title":"Recent advances in diagnosis and management of ischemic heart diseases in perspective of contemporary and Ayurveda medicine—a comprehensive review","authors":"Aishwarya Joglekar, M. Vyas, M. Bhojani","doi":"10.4103/jism.jism_92_22","DOIUrl":"https://doi.org/10.4103/jism.jism_92_22","url":null,"abstract":"Ischemic heart disease (IHD) or commonly known as coronary heart disease is considered as of the important cause of morbidity and mortality across the globe. This condition affects both the structure and function of heart muscle. Its prevalence should be considered since the advent of human life as even classical texts of Ayurveda have given ample emphasis on physiology and pathology of Hridroga (heart diseases). This is thus a topic of interest for the cardiologists, Ayurveda physicians, and general physicians. In order to cope with the transformations in the field of medicine, especially critical care, one must be well versed with the recent advances especially concerning this critical field of cardiology. The available classical literature regarding Hridroga and contemporary literature pertaining to IHD is reviewed in the present study with the help of robust search of different databases, published scientific works to present solid knowledge foundation for effective diagnosis, management, and research opportunities concerning filed of cardiology. The advances concerning the different clinical and preclinical trials on interventional drugs in treatment of IHD along with the different observational and exploratory studies done to understand the pathophysiology of Hridroga are highlighted in this article. Encouraging findings were achieved by the means of a thorough review put forth in the article which elaborates to highlight the recent advances in the research, diagnosis, management, and prevention of IHD in terms of both Ayurvedic and contemporary approaches.","PeriodicalId":16051,"journal":{"name":"Journal of Indian System of Medicine","volume":"121 1","pages":"41 - 50"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86274658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of hypothyroidism with the help of principles of Anukta disease concept: A case study 运用Anukta病概念治疗甲状腺功能减退:个案研究
Pub Date : 2022-10-01 DOI: 10.4103/jism.jism_36_22
Amruta S Suryawanshi, P. Kulkarni
Lack of thyroid hormone and resistance of the body tissue to thyroid hormone with respect to metabolic demand result in disorder called hypothyroidism. As per conventional science, Synthetic thyroid hormone used to manage hypothyroidism makes the patient drug dependent and still not helping in resolving underlying pathology. Hence Ayurveda is opted for study and to manage the conditions like hypothyroidism by means of Ayurvedic principle like anukta vyadhi vichar (Unstated Disease Concept): In this case, a female patient of age 35 yrs old had complainets of shwasakashtata (Breathlessness), mukhashotha (facial puffiness), hrudadrava (Palpitations), daurbalya (Weakness) was examined thoroughly with the help of ayurvedic methodology aspect like Dashavidha pariksha as patient has kaphapitta pradhan hetu and lakshana hence diagnosed as kaphaj pandu awastha as stated in classics. Treatment protocol given in samhita for this particularly diagnosed kaphaj pandu awastha which is samshodhana (Purification), Snehana (oleation) and shamana (internal medicines) was followed and successfully treated. Symptomatic relief and to wean the patient off the synthetic hormone supplement are the intent to treat the condition of hypothyroidism in this patient. This case study concludes that by means principle of Anukta vyadhi vichar, one can diagnose and successfully manage the conditions like hypothyroidism which are not stated in ayurvedic classics.
甲状腺激素的缺乏和身体组织对甲状腺激素代谢需求的抵抗导致甲状腺功能减退症。根据传统科学,用于治疗甲状腺功能减退的合成甲状腺激素使患者对药物依赖,仍然无助于解决潜在的病理。因此,阿育吠陀被选择用于研究和通过阿育吠陀原理如anukta vyadhi vichar(未说明的疾病概念)来管理甲状腺功能减退等疾病:在这种情况下,一名35岁的女性患者抱怨呼吸困难,面部浮肿,心悸,虚弱,在阿育吠陀方法的帮助下,如Dashavidha pariksha等方面进行了彻底的检查,因为患者有kaphapitta pradhan hetu和lakshana,因此诊断为kaphaj pandu awastha。在samhita中给出的治疗方案是针对这种特别诊断的kaphaj pandu awastha,即samshodhana(净化),Snehana(油酸)和shamana(内部药物),并成功治疗。本例患者甲状腺功能减退的治疗目的是缓解症状并使患者脱离合成激素的补充。本案例研究的结论是,通过Anukta vyadhi vichar原理,人们可以诊断并成功管理阿育吠陀经典中未述及的甲状腺功能减退等疾病。
{"title":"Management of hypothyroidism with the help of principles of Anukta disease concept: A case study","authors":"Amruta S Suryawanshi, P. Kulkarni","doi":"10.4103/jism.jism_36_22","DOIUrl":"https://doi.org/10.4103/jism.jism_36_22","url":null,"abstract":"Lack of thyroid hormone and resistance of the body tissue to thyroid hormone with respect to metabolic demand result in disorder called hypothyroidism. As per conventional science, Synthetic thyroid hormone used to manage hypothyroidism makes the patient drug dependent and still not helping in resolving underlying pathology. Hence Ayurveda is opted for study and to manage the conditions like hypothyroidism by means of Ayurvedic principle like anukta vyadhi vichar (Unstated Disease Concept): In this case, a female patient of age 35 yrs old had complainets of shwasakashtata (Breathlessness), mukhashotha (facial puffiness), hrudadrava (Palpitations), daurbalya (Weakness) was examined thoroughly with the help of ayurvedic methodology aspect like Dashavidha pariksha as patient has kaphapitta pradhan hetu and lakshana hence diagnosed as kaphaj pandu awastha as stated in classics. Treatment protocol given in samhita for this particularly diagnosed kaphaj pandu awastha which is samshodhana (Purification), Snehana (oleation) and shamana (internal medicines) was followed and successfully treated. Symptomatic relief and to wean the patient off the synthetic hormone supplement are the intent to treat the condition of hypothyroidism in this patient. This case study concludes that by means principle of Anukta vyadhi vichar, one can diagnose and successfully manage the conditions like hypothyroidism which are not stated in ayurvedic classics.","PeriodicalId":16051,"journal":{"name":"Journal of Indian System of Medicine","volume":"3 1","pages":"276 - 280"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81846820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Pharmacognostical and physicochemical profile of Abhayadi Gutika: An polyherbal formulation 古提卡的生药学和理化特征:一种多草药配方
Pub Date : 2022-10-01 DOI: 10.4103/jism.jism_68_22
Sunny Patil, A. Baghel, S. Kamble, H. Rudrappa, V. Shukla, M. Mehta
Introduction: Quality standardization and maintenance of these standards is the need of the hour in this era which is showing growing demand for traditional medicines. Although Abhayadi Gutika (AG) is an important formulation in Ayurvedic pharmacopeia, it lacks scientific documentation. Aims: The aim was to study organoleptic, microscopic, physicochemical, phytochemical, nutraceutical, and high-performance thin-layer chromatography (HPTLC) profile of AG. Materials and Methods: AG was prepared and subjected to pharmacognostical analysis in which organoleptic and microscopic characteristics were identified. This was followed by analytical study comprising physicochemical, phytochemical, neutraceutical parameters, acid-neutralizing capacity, and HPTLC profile. Results: Pharmacognostical microscopic evaluation revealed the presence of starch grains, acicular crystals, group of fibers, sclereids, stone cells, and epicarp cells. Quantitative physicochemical analysis revealed loss on drying value as 6.37% w/w, ash value as 2.16% w/w, water-soluble extractive value as 44.37% w/w, alcohol-soluble extractive value as 37.91% w/w, and pH value as 6.5. Phytochemical analysis showed the presence of flavonoids, saponins, and tannins in the finished product. In nutraceutical evaluation, functionalities such as total proteins (4.82%), total fats (0.5%), total carbohydrates (70.48%), total sugars (48%), and crude fibers (2.5%) were observed. Acid-neutralizing capacity for AG was found to be 1.3 meq/gm. HPTLC fingerprinting exhibited five peaks (Rf values: 0.18, 0.28, 0.72, 0.81, 0.84) at 254 nm, seven peaks (Rf values: 0.09, 0.22, 0.25, 0.28, 0.53, 0.58, 0.64) at 366 nm and two peaks (Rf values: 0.64, 0.72) at 540 nm on densitogram. Conclusion: Preliminary profiling of AG exhibited striking pharmacognostical as well as analytical characteristics. In nutraceutical analysis, functionalities like proteins, fats, carbohydrates, sugars and crude fibers were observed. Acid-neutralizing capacity which is a measure of efficacy of medicines prescribed for hyperacidity (antacids) was found to be 1.3 meq/gm for AG which supports its therapeutic efficacy in the disease conditions like Vidagdhajirna.
导言:在这个对传统药物需求日益增长的时代,质量标准化和这些标准的维护是当务之急。虽然Abhayadi Gutika (AG)是阿育吠陀药典中的一个重要配方,但缺乏科学文献。目的:研究AG的感官、显微、理化、植物化学、营养成分及高效薄层色谱(HPTLC)图谱。材料与方法:制备AG并对其进行生药学分析,鉴定其感官和显微特征。随后进行了分析研究,包括理化、植物化学、中性药物参数、酸中和能力和HPTLC谱。结果:生药学镜检显示淀粉粒、针状晶体、纤维群、硬核细胞、石细胞和外果皮细胞。定量理化分析表明,干燥值损失为6.37% w/w,灰分值为2.16% w/w,水溶性萃取值为44.37% w/w,醇溶萃取值为37.91% w/w, pH值为6.5。植物化学分析表明,成品中含有黄酮类化合物、皂苷和单宁。在营养评价方面,观察了总蛋白质(4.82%)、总脂肪(0.5%)、总碳水化合物(70.48%)、总糖(48%)和粗纤维(2.5%)等功能。AG的酸中和能力为1.3 meq/gm。在254 nm处有5个峰(Rf值分别为0.18、0.28、0.72、0.81、0.84),在366 nm处有7个峰(Rf值分别为0.09、0.22、0.25、0.28、0.53、0.58、0.64),在540 nm处有2个峰(Rf值分别为0.64、0.72)。结论:AG的初步图谱具有显著的生药学和分析学特征。在营养分析中,观察了蛋白质、脂肪、碳水化合物、糖和粗纤维等功能。酸中和能力是衡量高酸性药物(抗酸药)疗效的指标,发现AG的酸中和能力为1.3 meq/gm,这支持了其对Vidagdhajirna等疾病的治疗效果。
{"title":"Pharmacognostical and physicochemical profile of Abhayadi Gutika: An polyherbal formulation","authors":"Sunny Patil, A. Baghel, S. Kamble, H. Rudrappa, V. Shukla, M. Mehta","doi":"10.4103/jism.jism_68_22","DOIUrl":"https://doi.org/10.4103/jism.jism_68_22","url":null,"abstract":"Introduction: Quality standardization and maintenance of these standards is the need of the hour in this era which is showing growing demand for traditional medicines. Although Abhayadi Gutika (AG) is an important formulation in Ayurvedic pharmacopeia, it lacks scientific documentation. Aims: The aim was to study organoleptic, microscopic, physicochemical, phytochemical, nutraceutical, and high-performance thin-layer chromatography (HPTLC) profile of AG. Materials and Methods: AG was prepared and subjected to pharmacognostical analysis in which organoleptic and microscopic characteristics were identified. This was followed by analytical study comprising physicochemical, phytochemical, neutraceutical parameters, acid-neutralizing capacity, and HPTLC profile. Results: Pharmacognostical microscopic evaluation revealed the presence of starch grains, acicular crystals, group of fibers, sclereids, stone cells, and epicarp cells. Quantitative physicochemical analysis revealed loss on drying value as 6.37% w/w, ash value as 2.16% w/w, water-soluble extractive value as 44.37% w/w, alcohol-soluble extractive value as 37.91% w/w, and pH value as 6.5. Phytochemical analysis showed the presence of flavonoids, saponins, and tannins in the finished product. In nutraceutical evaluation, functionalities such as total proteins (4.82%), total fats (0.5%), total carbohydrates (70.48%), total sugars (48%), and crude fibers (2.5%) were observed. Acid-neutralizing capacity for AG was found to be 1.3 meq/gm. HPTLC fingerprinting exhibited five peaks (Rf values: 0.18, 0.28, 0.72, 0.81, 0.84) at 254 nm, seven peaks (Rf values: 0.09, 0.22, 0.25, 0.28, 0.53, 0.58, 0.64) at 366 nm and two peaks (Rf values: 0.64, 0.72) at 540 nm on densitogram. Conclusion: Preliminary profiling of AG exhibited striking pharmacognostical as well as analytical characteristics. In nutraceutical analysis, functionalities like proteins, fats, carbohydrates, sugars and crude fibers were observed. Acid-neutralizing capacity which is a measure of efficacy of medicines prescribed for hyperacidity (antacids) was found to be 1.3 meq/gm for AG which supports its therapeutic efficacy in the disease conditions like Vidagdhajirna.","PeriodicalId":16051,"journal":{"name":"Journal of Indian System of Medicine","volume":"93 1","pages":"221 - 227"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80273343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The formulations in Rasayogsagar for treating toxicity: Critical review 治疗毒性的中药制剂综述
Pub Date : 2022-10-01 DOI: 10.4103/jism.jism_50_22
N. Pandey, Anita Sharma, A. Kadu, K. Das, Naresh Itani, S. Pokhrel
Background: In the current era, different toxicants are a major problem for human Owing to industrialization and civilization, people are embedded in the test-tube of toxins. Different kinds of toxicants, which are called xenobiotics, found in the form of chemicals, pesticides, coloring agents, and antibiotics, which enter into the body through different routes such as oral, dermal, and inhalation, play an important role as a etiological factor for the pathology of different diseases such as hypertension, diabetes mellitus, cancer, and so on. All these artificial poisons are considered to be Kritrim Visha, which are also called Gara Visha in Ayurveda, which is described to be one of the causative factors to cause disease conditions. So, it is necessary to identify those preparations or formulations which act as an anti-toxic action. The classical text, i.e., Rasayogsagar, has mentioned thousands of preparations, among them about 74 are Vishaghna Yoga (anti-toxic preparations) which have been specifically indicated either in animate or in inanimate toxicity or in both. These formulations in the modern era have a great importance to reduce the toxicity level in human beings. So, these preparations must be prepared and made available everywhere following the guidelines of preparation mentioned in Rasayogsagar, which could play to pacify the toxic substance and prevent the harmful effects in human beings. Aims and Objectives: The aim of this study is as follows: (i) To study the indication of different preparations mentioned in Rasayogsagar for different toxic manifestations. (ii) A detailed literary study of contents and methods of preparations of Vishaghna (anti-toxic) with doses and route of administration. Materials and Methods: The article is based on literary review regarding anti-toxic action (Vishaghna) of various kinds of preparations, which has been collected and compiled from Ayurvedic compendium (i.e., Rasayogsagar). Results and Conclusion: In total, 74 anti-toxic (Vishaghna) formulations have been found in Rasayogsagar. Most of them have found to be specifically indicated in anti-toxic action-specific (Visha Rogadhikar) and some of them have been indicated in other disease conditions but have anti-toxic properties (Vishaghna) also.
背景:在当今时代,不同的有毒物质是人类面临的主要问题。由于工业化和文明的发展,人们被埋在毒素的试管中。以化学药品、农药、着色剂、抗生素等形式存在的各种有毒物质被称为异种生物素,它们通过口服、皮肤和吸入等不同途径进入人体,在高血压、糖尿病、癌症等不同疾病的病理中起着重要的病因作用。所有这些人造毒药都被认为是克里特里姆维沙,在阿育吠陀中也被称为加拉维沙,它被描述为引起疾病的原因之一。因此,有必要确定具有抗毒性作用的制剂或制剂。经典典籍,即《Rasayogsagar》,提到了数千种制剂,其中约74种是维沙格那瑜伽(抗毒制剂),它们被明确指出具有生命毒性或无生命毒性,或两者都具有。这些配方在现代对降低人体毒性水平具有重要意义。因此,这些制剂必须按照Rasayogsagar中提到的制剂指南进行准备,并在任何地方提供,这可以起到安抚有毒物质和防止对人类有害影响的作用。目的和目的:本研究的目的如下:(1)研究不同制剂对不同毒性表现的适应证。(ii)详细的文献研究Vishaghna(抗毒性)的内容和制备方法,剂量和给药途径。材料与方法:本文基于从阿育吠陀纲目(即Rasayogsagar)中收集和汇编的关于各种制剂的抗毒作用(Vishaghna)的文献综述。结果与结论:共检出抗毒制剂74种。其中大多数已被发现专门用于抗毒性行动(Visha Rogadhikar),其中一些已被用于其他疾病条件,但也具有抗毒性特性(Vishaghna)。
{"title":"The formulations in Rasayogsagar for treating toxicity: Critical review","authors":"N. Pandey, Anita Sharma, A. Kadu, K. Das, Naresh Itani, S. Pokhrel","doi":"10.4103/jism.jism_50_22","DOIUrl":"https://doi.org/10.4103/jism.jism_50_22","url":null,"abstract":"Background: In the current era, different toxicants are a major problem for human Owing to industrialization and civilization, people are embedded in the test-tube of toxins. Different kinds of toxicants, which are called xenobiotics, found in the form of chemicals, pesticides, coloring agents, and antibiotics, which enter into the body through different routes such as oral, dermal, and inhalation, play an important role as a etiological factor for the pathology of different diseases such as hypertension, diabetes mellitus, cancer, and so on. All these artificial poisons are considered to be Kritrim Visha, which are also called Gara Visha in Ayurveda, which is described to be one of the causative factors to cause disease conditions. So, it is necessary to identify those preparations or formulations which act as an anti-toxic action. The classical text, i.e., Rasayogsagar, has mentioned thousands of preparations, among them about 74 are Vishaghna Yoga (anti-toxic preparations) which have been specifically indicated either in animate or in inanimate toxicity or in both. These formulations in the modern era have a great importance to reduce the toxicity level in human beings. So, these preparations must be prepared and made available everywhere following the guidelines of preparation mentioned in Rasayogsagar, which could play to pacify the toxic substance and prevent the harmful effects in human beings. Aims and Objectives: The aim of this study is as follows: (i) To study the indication of different preparations mentioned in Rasayogsagar for different toxic manifestations. (ii) A detailed literary study of contents and methods of preparations of Vishaghna (anti-toxic) with doses and route of administration. Materials and Methods: The article is based on literary review regarding anti-toxic action (Vishaghna) of various kinds of preparations, which has been collected and compiled from Ayurvedic compendium (i.e., Rasayogsagar). Results and Conclusion: In total, 74 anti-toxic (Vishaghna) formulations have been found in Rasayogsagar. Most of them have found to be specifically indicated in anti-toxic action-specific (Visha Rogadhikar) and some of them have been indicated in other disease conditions but have anti-toxic properties (Vishaghna) also.","PeriodicalId":16051,"journal":{"name":"Journal of Indian System of Medicine","volume":"6 1","pages":"234 - 240"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76427328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
External applications of Shigru (Moringa oleifera Lam): A comprehensive review 辣木的外用研究综述
Pub Date : 2022-10-01 DOI: 10.4103/jism.jism_48_22
Swati Gavadiya, Tarun Sharma, V. Bapna
Background: Plants are the main source of medicine in traditional system of medicines like Ayurveda. In Ayurvedic literature, there are indications of Basti (drug administration through anal route) and Nasya (drug administration through nasal route) along with oral route. Similarly, for external application, there were many forms such as lepa (external application of paste), Aschyotana (eye drops), Anjana (collyrium), etc. The Ayurveda literature is a treasure of many formulations that can be therapeutically used through various routes in Netra roga (eye disorders), Karna roga (ear disorders), Kustha (skin diseases), Apsmara (epilepsy), Galganda (goitre), and Slipada (elephantiasis). Systematic monographs of single drugs can be very useful for clinical application. Moringa oleifera is a single drug, which is abundantly available as well as therapeutically efficacious; this review is an appraisal to compile and present the external therapeutic uses of Shigru (Moringa oleifera Lam). Aim: The aim of the study was to review the Ayurvedic literature to collect information regarding the external therapeutic use of various parts of Shigru. Materials and Methods: Extensive review of Shigru involves the study of Veda, Samhita, Chikitsa granth, Ayurvedic compendia, and various databases like database of India, etc., regarding various formulations, dosage form, indications, and useful parts. Result: During the literature survey, a total of 149 formulations in 145 dosage forms of Shigru have been recommended for 24 diseases. Conclusions: Shigru is extensively useful for external application, and based on the information presented in this literature survey, it can be therapeutically used in many diseases as well as novel formulations and dosage forms using Shigru (Moringa oleifera Lam).
背景:在阿育吠陀等传统医学体系中,植物是药物的主要来源。在阿育吠陀文献中,有Basti(通过肛门给药)和Nasya(通过鼻腔给药)以及口服给药的适应症。同样,外敷也有多种形式,如lepa(贴外敷)、Aschyotana(滴眼液)、Anjana(眼药水)等。阿育吠陀文献是许多配方的宝藏,可以通过Netra roga(眼部疾病),Karna roga(耳部疾病),Kustha(皮肤病),Apsmara(癫痫),Galganda(甲状腺肿)和Slipada(象皮病)的各种途径进行治疗。单一药物的系统专著对临床应用非常有用。辣木是一种单一的药物,它是丰富的,而且治疗有效;本文综述了辣木(Moringa oleifera Lam)的外治疗用途。目的:本研究的目的是回顾阿育吠陀文献,以收集有关Shigru各部分外用治疗的信息。材料和方法:对shiigru的广泛审查涉及吠陀,Samhita, Chikitsa granth,阿育吠陀纲目的研究,以及各种数据库,如印度数据库等,涉及各种配方,剂型,适应症和有用部分。结果:在文献调查中,共推荐石毒145个剂型149个剂型,用于24种疾病。结论:石毒具有广泛的外用价值,根据本文献综述提供的信息,石毒可用于多种疾病的治疗,也可用于新的配方和剂型。
{"title":"External applications of Shigru (Moringa oleifera Lam): A comprehensive review","authors":"Swati Gavadiya, Tarun Sharma, V. Bapna","doi":"10.4103/jism.jism_48_22","DOIUrl":"https://doi.org/10.4103/jism.jism_48_22","url":null,"abstract":"Background: Plants are the main source of medicine in traditional system of medicines like Ayurveda. In Ayurvedic literature, there are indications of Basti (drug administration through anal route) and Nasya (drug administration through nasal route) along with oral route. Similarly, for external application, there were many forms such as lepa (external application of paste), Aschyotana (eye drops), Anjana (collyrium), etc. The Ayurveda literature is a treasure of many formulations that can be therapeutically used through various routes in Netra roga (eye disorders), Karna roga (ear disorders), Kustha (skin diseases), Apsmara (epilepsy), Galganda (goitre), and Slipada (elephantiasis). Systematic monographs of single drugs can be very useful for clinical application. Moringa oleifera is a single drug, which is abundantly available as well as therapeutically efficacious; this review is an appraisal to compile and present the external therapeutic uses of Shigru (Moringa oleifera Lam). Aim: The aim of the study was to review the Ayurvedic literature to collect information regarding the external therapeutic use of various parts of Shigru. Materials and Methods: Extensive review of Shigru involves the study of Veda, Samhita, Chikitsa granth, Ayurvedic compendia, and various databases like database of India, etc., regarding various formulations, dosage form, indications, and useful parts. Result: During the literature survey, a total of 149 formulations in 145 dosage forms of Shigru have been recommended for 24 diseases. Conclusions: Shigru is extensively useful for external application, and based on the information presented in this literature survey, it can be therapeutically used in many diseases as well as novel formulations and dosage forms using Shigru (Moringa oleifera Lam).","PeriodicalId":16051,"journal":{"name":"Journal of Indian System of Medicine","volume":"14 1","pages":"241 - 250"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84872491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low back pain: the riveting history with unexplored ancient Indian knowledge 腰痛:引人入胜的历史与未开发的古印度知识
Pub Date : 2022-10-01 DOI: 10.4103/jism.jism_75_22
P. Verma, Shiwangi Kanaujia, A. Pathak
Introduction: Low back pain affects 70–85% of the adult population at some point in life. In total 45–75% of patients continue to experience pain after 12 months of onset. Low back pain is a major health hazard in today’s technological era. The history of low back pain is as ancient as human civilization. There are pieces of evidence of low back pain and sciatica in the past era, which was a problematic concern for the population of that time. There was a practical approach of different cultures toward the low back and sciatic pain at that time. The rich history of Indian medicine guides us to the classic developments and thoughts of that era. Aims and Objectives: This study aims to illuminate descriptions and understandings of low back pain from previous historical reviews as well as fill gaps in previous reviews that ignored the hidden knowledge of low back pain from ancient Indian literature. Materials and Methods: Here published scientific articles in reputed journals regarding the historical background of low back pain, sciatica, and lumbar radiculopathy have been reviewed from PubMed, Google Scholar, Scopus, and so on, and low back pain conditions from ayurveda classics have been extracted and conceptual understanding to low back pain by ancient Indian ayurvedic scholars have been revealed. The lacunae in previous reviews of missing the knowledge of ancient Indian ayurvedic texts have been tried to fill by this work. Observations and Results: The review showed that the understanding of various conditions associated with low back pain such as katishoola, katigraha, gridhrasi, trikshoola, trikvedna, and so on. and its pathophysiology was well developed in ancient Indian culture. Conclusion: Numerous earlier studies on low back and sciatic pain have overlooked the historical significance of the Indian subcontinent. The existing information must therefore be revealed along with these crucial descriptions. The world’s focus will be directed toward ayurvedic medicines and low back pain management solutions when the concepts of ayurveda are revealed historically. As a result, this article will aid in promoting the traditional Ayurvedic medical method.
引言:70-85%的成年人在生命的某个阶段都患有腰痛。总的来说,45-75%的患者在发病12个月后仍然感到疼痛。在当今的科技时代,腰痛是一个主要的健康危害。腰痛的历史与人类文明一样古老。有证据表明,在过去的时代有腰痛和坐骨神经痛,这对当时的人们来说是一个问题。当时对于腰背部和坐骨疼痛有不同文化背景的实用方法。印度医学的丰富历史引导我们了解那个时代的经典发展和思想。目的和目的:本研究旨在阐明以往文献对腰痛的描述和理解,填补以往文献忽视古印度文献中关于腰痛的隐性知识的空白。材料与方法:通过PubMed、谷歌Scholar、Scopus等知名期刊上发表的关于腰痛、坐骨神经痛、腰椎神经根病历史背景的科学文章进行综述,提取阿育吠陀经典中的腰痛病症,揭示古印度阿育吠陀学者对腰痛的概念性认识。在以前的评论中缺少对古印度阿育吠陀文本的知识的空白已经试图通过这项工作来填补。观察与结果:综述显示对与腰痛相关的各种疾病如katishoola、katigraha、gridhrasi、trikshoola、trikvedna等的了解。其病理生理在古印度文化中得到了很好的发展。结论:许多关于腰背部和坐骨疼痛的早期研究忽视了印度次大陆的历史意义。因此,现有的信息必须与这些关键的描述一起披露。当阿育吠陀的概念被历史地揭示出来时,世界的焦点将指向阿育吠陀药物和腰痛管理解决方案。因此,本文将有助于推广传统的阿育吠陀医学方法。
{"title":"Low back pain: the riveting history with unexplored ancient Indian knowledge","authors":"P. Verma, Shiwangi Kanaujia, A. Pathak","doi":"10.4103/jism.jism_75_22","DOIUrl":"https://doi.org/10.4103/jism.jism_75_22","url":null,"abstract":"Introduction: Low back pain affects 70–85% of the adult population at some point in life. In total 45–75% of patients continue to experience pain after 12 months of onset. Low back pain is a major health hazard in today’s technological era. The history of low back pain is as ancient as human civilization. There are pieces of evidence of low back pain and sciatica in the past era, which was a problematic concern for the population of that time. There was a practical approach of different cultures toward the low back and sciatic pain at that time. The rich history of Indian medicine guides us to the classic developments and thoughts of that era. Aims and Objectives: This study aims to illuminate descriptions and understandings of low back pain from previous historical reviews as well as fill gaps in previous reviews that ignored the hidden knowledge of low back pain from ancient Indian literature. Materials and Methods: Here published scientific articles in reputed journals regarding the historical background of low back pain, sciatica, and lumbar radiculopathy have been reviewed from PubMed, Google Scholar, Scopus, and so on, and low back pain conditions from ayurveda classics have been extracted and conceptual understanding to low back pain by ancient Indian ayurvedic scholars have been revealed. The lacunae in previous reviews of missing the knowledge of ancient Indian ayurvedic texts have been tried to fill by this work. Observations and Results: The review showed that the understanding of various conditions associated with low back pain such as katishoola, katigraha, gridhrasi, trikshoola, trikvedna, and so on. and its pathophysiology was well developed in ancient Indian culture. Conclusion: Numerous earlier studies on low back and sciatic pain have overlooked the historical significance of the Indian subcontinent. The existing information must therefore be revealed along with these crucial descriptions. The world’s focus will be directed toward ayurvedic medicines and low back pain management solutions when the concepts of ayurveda are revealed historically. As a result, this article will aid in promoting the traditional Ayurvedic medical method.","PeriodicalId":16051,"journal":{"name":"Journal of Indian System of Medicine","volume":"152 1","pages":"256 - 264"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77390761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The need for an interdisciplinary strategy for a better quality of living 需要一个跨学科的战略来提高生活质量
Pub Date : 2022-10-01 DOI: 10.4103/jism.jism_101_22
Vaishali Kuchewar
{"title":"The need for an interdisciplinary strategy for a better quality of living","authors":"Vaishali Kuchewar","doi":"10.4103/jism.jism_101_22","DOIUrl":"https://doi.org/10.4103/jism.jism_101_22","url":null,"abstract":"","PeriodicalId":16051,"journal":{"name":"Journal of Indian System of Medicine","volume":"1 1","pages":"219 - 220"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79779840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic indications of formulations of Kapardika Bhasma (Cowrie calx) described in bharat bhaishajya ratnakar 在bharat bhaishajya ratnakar中描述的Kapardika Bhasma (corie calx)配方的治疗适应症
Pub Date : 2022-10-01 DOI: 10.4103/jism.jism_60_22
Pranjali Dukare, B. Rathi, A. Wanjari, Mujahid B. Khan
Introduction: Kapardika (Cypraeamoneta) is one of the animal origin drug mentioned in Rasashastra. According to different texts Kapardika (Cypraeamoneta) is classified under two categories they are Sudha Varga (Calcium component drugs) and Sadharana Rasa Varga (Herbal origin drug) Its medicinal usage is known since Vedic era and was used to treat various ailments effectively. Aim and Objective: Aim of the present study is to collect the formulations containing Kapardika Bhasma (Cypraeamoneta Powder) described in the text Bharat Bhaishajya Ratnakar and find out its therapeutic efficacy. Materials and Methods: All the formulations containing Kapardika bhasma (Cypraeamoneta Powder) are reviewed from all the five volumes of Bharat Bheshaja Ratnakar and again categorized according to its dosage forms. Observation and Results: Total 42 formulations containing Kapardika Bhasma (Cypraeamoneta Powder) have been reviewed which are indicated in Agnimandya (Loss of appetite), Parinamshula (Duodenal ulcer), Grahani (Malabsorption syndrome), Rajaykshma (Tuberculosis), Karnasrava (Ottorhoea), Netraroga (Diseases of the eye), and Sukraksaya (Oligospermia). These formulations are advised to be taken in different dosage forms such as Anjana (Collyrium) Vati (Tablets), Pottali (Bundle) etc. Conclusion: The present work will be valuable in recognition of newer formulations of Kapardika Bhasma (Cypraeamoneta Powder) and their therapeutic applications in various ailments.
简介:Kapardika (Cypraeamoneta)是Rasashastra中提到的一种动物源性药物。根据不同的文献,Kapardika (Cypraeamoneta)被分为两类,它们是Sudha Varga(钙成分药物)和Sadharana Rasa Varga(草药来源药物),它的药用用途自吠陀时代就知道,被用来有效地治疗各种疾病。目的与目的:本研究的目的是收集文献《Bharat Bhaishajya Ratnakar》中所描述的含有香草粉的配方,并找出其治疗效果。材料和方法:从《巴拉特·比什哈贾·拉纳卡》五卷中回顾了所有含有卡帕迪卡·巴什玛(Cypraeamoneta Powder)的配方,并根据其剂型再次分类。观察与结果:综述了共42种含有Kapardika Bhasma (Cypraeamoneta Powder)的制剂,其中包括Agnimandya(食欲不振)、Parinamshula(十二指肠溃疡)、Grahani(吸收不良综合征)、Rajaykshma(结核病)、Karnasrava (Ottorhoea)、Netraroga(眼病)和Sukraksaya(少精子症)。这些配方建议以不同的剂型服用,如Anjana (Collyrium) Vati(片剂)Pottali(捆绑剂)等。结论:本工作对新剂型的开发及其在各种疾病中的应用具有一定的参考价值。
{"title":"Therapeutic indications of formulations of Kapardika Bhasma (Cowrie calx) described in bharat bhaishajya ratnakar","authors":"Pranjali Dukare, B. Rathi, A. Wanjari, Mujahid B. Khan","doi":"10.4103/jism.jism_60_22","DOIUrl":"https://doi.org/10.4103/jism.jism_60_22","url":null,"abstract":"Introduction: Kapardika (Cypraeamoneta) is one of the animal origin drug mentioned in Rasashastra. According to different texts Kapardika (Cypraeamoneta) is classified under two categories they are Sudha Varga (Calcium component drugs) and Sadharana Rasa Varga (Herbal origin drug) Its medicinal usage is known since Vedic era and was used to treat various ailments effectively. Aim and Objective: Aim of the present study is to collect the formulations containing Kapardika Bhasma (Cypraeamoneta Powder) described in the text Bharat Bhaishajya Ratnakar and find out its therapeutic efficacy. Materials and Methods: All the formulations containing Kapardika bhasma (Cypraeamoneta Powder) are reviewed from all the five volumes of Bharat Bheshaja Ratnakar and again categorized according to its dosage forms. Observation and Results: Total 42 formulations containing Kapardika Bhasma (Cypraeamoneta Powder) have been reviewed which are indicated in Agnimandya (Loss of appetite), Parinamshula (Duodenal ulcer), Grahani (Malabsorption syndrome), Rajaykshma (Tuberculosis), Karnasrava (Ottorhoea), Netraroga (Diseases of the eye), and Sukraksaya (Oligospermia). These formulations are advised to be taken in different dosage forms such as Anjana (Collyrium) Vati (Tablets), Pottali (Bundle) etc. Conclusion: The present work will be valuable in recognition of newer formulations of Kapardika Bhasma (Cypraeamoneta Powder) and their therapeutic applications in various ailments.","PeriodicalId":16051,"journal":{"name":"Journal of Indian System of Medicine","volume":"97 4 1","pages":"251 - 255"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72808291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National webinar on newer teaching–learning methods and assessment modules in Ayurved education 全国网络研讨会:在传统教育中更新的教学方法和评估模块
Pub Date : 2022-10-01 DOI: 10.4103/jism.jism_100_22
A. Deshpande, G. Sawarkar
{"title":"National webinar on newer teaching–learning methods and assessment modules in Ayurved education","authors":"A. Deshpande, G. Sawarkar","doi":"10.4103/jism.jism_100_22","DOIUrl":"https://doi.org/10.4103/jism.jism_100_22","url":null,"abstract":"","PeriodicalId":16051,"journal":{"name":"Journal of Indian System of Medicine","volume":"12 1","pages":"287 - 288"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87907410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Indian System of Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1